Drimva

GSK

Oncology Account Manager (Solid Tumor) Baltimore North

$161K–$269K

USA - Maryland - Baltimore +3 · Field worker · Manager · Full-time · Posted Sep 28, 2026

Location
USA - Maryland - Baltimore
USA - Maryland - Frederick
USA - Maryland - Towson
USA - Maryland - Bel Air
Experience
Minimum 3 years in pharmaceutical, biologic, specialty sales, or clinical oncology experience; preferred qualification includes two or more years of oncology or specialty sales experience.
Education
Bachelor’s degree (BA/BS) from an accredited institution.

About the job

Manages a North Baltimore-area territory, building oncology care team relationships and executing business plans to improve patient access and achieve measurable results.

What you'll do

  • Build relationships with oncologists, specialty pharmacists, nurse navigators, and institutional accounts; identify priority prescribers and accounts.
  • Create and execute territory plans, using customer insights and data to prioritize actions and measure performance.
  • Coordinate with cross-functional partners on patient access, therapy availability, launches, and compliant local promotional programs.

What they ask for

  • Bachelor’s degree (BA/BS) from an accredited institution.
  • Minimum 3 years pharmaceutical, biologic, specialty sales, or clinical oncology experience with direct physician or institutional engagement.
  • Valid driver’s license and ability to drive within the assigned territory; driving is an essential function.
  • Reside within the assigned territory; ability to travel 30–50% depending on territory needs, including occasional overnight stays and weekend conferences.

Nice to have

  • Two or more years of oncology or specialty sales experience; health system or institutional account experience preferred.
  • Experience with hematology or solid tumor therapies, infusion products, specialty pharmacy, payer engagement, or account-based strategies.

Pay

$161,250 to $268,750 USD (annual base salary)

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 5, 2026 (UTC)